Therapeutics for 'Silent' Cancers
The global market for “silent” cancers was valued at $8.5 billion in 2013 and $9 billion in 2014. This market is expected to reach almost $13.6 billion by 2019, with a compound annual growth rate (CAGR) of 8.5% from 2014 to 2019.
- An overview of the global markets and technologies for the therapeutics for "silent" cancers.
- Analyses of global market trends, with data from 2013, 2014, and projections of CAGRs through 2019.
- Descriptions of cancers, with incidence and prevalence data for all major national markets.
- Assessments of currently available therapies.
- Evaluation of new agents now in clinical development, with likely launch timetables and estimates of potential clinical value.
- Profiles of major players in the "silent" cancer therapeutics industry.
SCOPE OF REPORT
The report discusses eight cancers described as “silent and deadly” because they are often undiagnosed until the diseases is advanced and difficult to treat. These cancers are brain, cervix, esophagus, mouth and larynx, ovary, pancreas, kidney, and lastly, liver. For each cancer, the cause, clinical course, diagnosis and treatment are described. Current drug therapy is outlined and new research activities are listed. The market is summarized and quantified for each cancer, with estimates of recent (2013) and current (2014) values for each cancer, and five-year projection to 2019. Geographically, the global market is given, with country analyses for the U.S., Japan, and five major Western European markets: Germany, France, Italy, Spain and the United Kingdom.
Paul Evers has been involved in analyzing pharmaceutical and medical markets for 20 years. He is the author of previous reports on the cancer marketplace as well as analyses of major therapeutic categories and the pharmaceutical regulatory environment.
When do I get the report?
Most reports are fulfilled immediately. In some cases, it could take up to 24 hours.
In what format does this report get delivered to me?
We will send you an email with login credentials to access the report. You will also be able to download the pdf.
What are the free reports included in my purchase?
They consist of a collection of current reports from various partner publishers scanning multiple industries.
What is the difference between BCC Research and BCC Publishing?
BCC Research curates thousands of reports from different sources and provides access to this content to our clients. BCC Publishing is the publication arm of BCC Research (one of several publishers in our portal).
What reports do I get 'discounts' on with my purchase?
All reports. BCC Publishing reports will be available for a 50% discount. All other partner publishers are also available at deeply discounted rates.
Where are you located?
Wellesley Massachusetts, just outside of Boston, Massachusetts, USA.
How long has BCC Research been around?
We are approaching our 50 year anniversary in 2021!
What if I want you to invoice me for payment via Purchase Order?
Simply choose Pay by Purchase Order when you are checking out. We will connect with you via email to set up your order.
What if I have a question about your reports?
Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available at all times, and included in every purchase, to help our customers find the research they need-when they need it.
Can I share this report with my team?
Absolutely yes, with the purchase of additional user licenses.
Can I use your research in my presentation?
Absolutely yes, so long as the publisher is properly cited.